NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is an American biopharmaceutical company that specializes in the development, manufacturing, and commercialization of non-antibiotic anti-infective products. The company was founded in 2000 and is headquartered in Emeryville, California.
History[edit]
NovaBay Pharmaceuticals was established in the year 2000 with the aim of developing innovative therapies for the treatment of a wide range of infections without causing antibiotic resistance. The company's initial focus was on the development of products that mimic the action of the human immune system.
Products[edit]
NovaBay Pharmaceuticals has developed several products, including Avenova, a prescription product for the management of blepharitis and the associated bacterial skin infection. Avenova is the only commercial product that contains NovaBay's proprietary, pure hypochlorous acid.
Research and Development[edit]
NovaBay Pharmaceuticals' research and development efforts are focused on the company's proprietary, pure hypochlorous acid. The company's research team is working on developing new formulations and applications for this compound.
Financials[edit]
As a publicly traded company, NovaBay Pharmaceuticals' financial performance is subject to regular reporting. The company's stock is traded on the New York Stock Exchange under the ticker symbol "NBY".
See Also[edit]
References[edit]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding the page. |
NovaBay Pharmaceuticals[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss blog | Philadelphia weight loss blog | Sleep medicine and sleep apnea services | W8MD MedSpa and wellness | Weight loss prescriptions
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
